Monsanto Company Profile (NYSE:MON)

About Monsanto

Monsanto logoMonsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, the Company produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds and precision agriculture to assist farmers in decision-making. It offers products, such as Germplasm and Biotechnology traits. Through its Agricultural Productivity segment, the Company manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: Agricultural Chemicals
  • Sub-Industry: Fertilizers & Agricultural Chemicals
  • Exchange: NYSE
  • Symbol: MON
  • CUSIP: 61166W10
Key Metrics:
  • Previous Close: $103.50
  • 50 Day Moving Average: $105.73
  • 200 Day Moving Average: $100.56
  • 52-Week Range: $82.81 - $114.26
  • Trailing P/E Ratio: 45.55
  • Foreward P/E Ratio: 21.12
  • P/E Growth: 3.47
  • Market Cap: $45.29B
  • Outstanding Shares: 437,575,000
  • Beta: 1.24
  • Net Margins: 7.76%
  • Return on Equity: 37.98%
  • Return on Assets: 9.07%
  • Debt-to-Equity Ratio: 1.55%
  • Current Ratio: 1.47%
  • Quick Ratio: 0.92%
Additional Links:
Companies Related to Monsanto:

Analyst Ratings

Consensus Ratings for Monsanto (NYSE:MON) (?)
Ratings Breakdown: 4 Sell Ratings, 5 Hold Ratings, 15 Buy Ratings
Consensus Rating:Hold (Score: 2.46)
Consensus Price Target: $112.55 (8.74% upside)

Analysts' Ratings History for Monsanto (NYSE:MON)
DateFirmActionRatingPrice TargetDetails
9/21/2016JPMorgan Chase & Co.UpgradeNeutral -> Overweight$128.00View Rating Details
9/15/2016Piper Jaffray Cos.Set Price TargetBuy$128.00View Rating Details
9/15/2016Sanford C. BernsteinReiterated RatingSellView Rating Details
9/15/2016BMO Capital MarketsSet Price TargetBuy$128.00View Rating Details
9/15/2016S&P Equity ResearchReiterated RatingPositiveView Rating Details
9/15/2016Deutsche Bank AGBoost Price TargetBuy$118.00 -> $128.00View Rating Details
9/15/2016Credit Agricole SADowngradeBuy -> Underperform$110.00View Rating Details
9/6/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/19/2016Citigroup Inc.Boost Price TargetNeutral$112.00 -> $116.00View Rating Details
8/8/2016Monness Crespi & HardtUpgradeNeutral -> Buy$106.93 -> $130.00View Rating Details
6/27/2016Goldman Sachs Group Inc.Set Price TargetSell$92.00View Rating Details
6/15/2016ArgusReiterated RatingBuy$111.00 -> $128.00View Rating Details
5/27/2016Atlantic SecuritiesDowngradeOverweight -> Neutral$109.62 -> $105.00View Rating Details
5/25/2016MacquarieSet Price TargetBuy$110.00View Rating Details
5/24/2016Wells Fargo & Co.Reiterated RatingHoldView Rating Details
5/23/2016Vertical ResearchUpgradeHold -> BuyView Rating Details
5/13/2016Berenberg BankSet Price TargetBuy$110.00View Rating Details
4/12/2016SusquehannaLower Price TargetPositive$105.00 -> $101.00View Rating Details
4/9/2016Morgan StanleyReiterated RatingBuyView Rating Details
4/7/2016Bank of America Corp.Reiterated RatingSell$88.00View Rating Details
3/3/2016Vertical GroupDowngradeBuy -> HoldView Rating Details
3/3/2016Barclays PLCLower Price TargetEqual Weight$100.00 -> $95.00View Rating Details
3/2/2016Credit Suisse Group AGLower Price TargetOutperform$109.00 -> $97.00View Rating Details
10/9/2015Stifel NicolausLower Price TargetBuy$135.00 -> $115.00View Rating Details
8/24/2015Canaccord GenuityReiterated RatingBuy$134.00 -> $126.00View Rating Details
5/6/2015BB&T Corp.Initiated CoverageHold -> HoldView Rating Details
1/20/2015Topeka Capital MarketsReiterated RatingHold$111.00View Rating Details
1/2/2015Miller TabakDowngradeBuy -> NeutralView Rating Details
(Data available from 9/25/2014 forward)


Earnings History for Monsanto (NYSE:MON)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/29/2016Q316$2.40$2.17$4.49 billion$4.19 billionViewListenView Earnings Details
4/6/2016Q216$2.44$2.42$4.81 billion$4.53 billionViewN/AView Earnings Details
1/6/2016Q116($0.22)($0.11)$2.41 billion$2.22 billionViewListenView Earnings Details
10/7/2015Q415($0.02)($0.19)$2.79 billion$2.36 billionViewListenView Earnings Details
6/24/2015Q315$2.06$2.39$4.58 billionViewListenView Earnings Details
4/1/2015Q215$2.93$2.90$5.58 billion$5.20 billionViewListenView Earnings Details
1/7/2015Q115$0.35$0.47$2.80 billion$2.87 billionViewListenView Earnings Details
10/8/2014Q414($0.23)($0.27)$2.41 billion$2.63 billionViewListenView Earnings Details
6/25/2014Q314$1.56$1.62$4.41 billion$4.25 billionViewListenView Earnings Details
4/2/2014Q214$3.08$3.15$5.81 billion$5.83 billionViewListenView Earnings Details
1/8/2014Q1$0.64$0.67$3.08 billion$3.15 billionViewListenView Earnings Details
10/2/2013Q413($0.43)($0.47)$2.24 billion$2.20 billionViewListenView Earnings Details
6/26/2013Q3 2013$1.59$1.66$4.41 billion$4.25 billionViewListenView Earnings Details
4/3/2013Q2 2013$2.58$2.73$5.29 billion$5.47 billionViewN/AView Earnings Details
1/8/2013Q1 2013$0.37$0.62$2.64 billion$2.93 billionViewListenView Earnings Details
10/3/2012Q412($0.43)($0.44)$2.25 billion$2.11 billionViewN/AView Earnings Details
6/27/2012$1.58$1.63ViewN/AView Earnings Details
4/4/2012$2.11$2.28ViewN/AView Earnings Details
1/5/2012$0.17$0.23ViewN/AView Earnings Details
10/5/2011($0.27)($0.22)ViewN/AView Earnings Details
4/6/2011$1.84$1.87ViewN/AView Earnings Details
1/6/2011$0.01$0.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Monsanto (NYSE:MON)
Current Year EPS Consensus Estimate: $4.44 EPS
Next Year EPS Consensus Estimate: $4.9 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$2.35$2.99$2.66
Q2 20163$2.29$2.73$2.50
Q3 20164($0.18)$0.15($0.02)
Q4 20162($0.08)$0.39$0.16
Q1 20171$3.57$3.57$3.57
Q2 20171$2.57$2.57$2.57
(Data provided by Zacks Investment Research)


Current Dividend Information for Monsanto (NYSE:MON)
Annual Dividend:$2.16
Dividend Yield:2.09%
Dividend Growth:16.40% (3 Year Average)
Payout Ratio:89.26% (Based on Trailing 12 Months of Earnings)
48.65% (Based on Current Year Consensus EPS Estimate)
44.08% (Based on Next Year Consensus EPS Estimate)
Track Record:6 Years of Consecutive Dividend Growth

Dividend History for Monsanto (NYSE:MON)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Monsanto (NYSE:MON)
Insider Ownership Percentage: 0.88%
Institutional Ownership Percentage: 79.06%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/14/2016Brett D BegemannCOOSell27,980$103.62$2,899,287.60View SEC Filing  
7/13/2016Michael K SternCEOSell12,797$101.77$1,302,350.69View SEC Filing  
4/19/2016George PosteDirectorSell1,136$91.93$104,432.48View SEC Filing  
4/14/2016Steven MizellEVPSell9,500$89.06$846,070.00View SEC Filing  
4/12/2016Charles S McmillanDirectorBuy3,500$87.25$305,375.00View SEC Filing  
4/12/2016Michael J FrankVPSell2,000$87.49$174,980.00View SEC Filing  
4/11/2016Steven MizellEVPSell3,900$86.87$338,793.00View SEC Filing  
11/17/2015Kerry J. PreeteEVPSell4,667$95.62$446,258.54View SEC Filing  
10/21/2015William U ParfetDirectorSell17,000$91.16$1,549,720.00View SEC Filing  
10/13/2015Steven MizellVPSell6,100$89.40$545,340.00View SEC Filing  
4/15/2015Kerry J PreeteEVPSell27,580$119.37$3,292,224.60View SEC Filing  
4/8/2015Tom D HartleyVPSell4,600$117.91$542,386.00View SEC Filing  
2/13/2015Michael K SternCOOSell1,391$125.00$173,875.00View SEC Filing  
1/20/2015David F SnivelyEVPSell29,521$117.14$3,458,089.94View SEC Filing  
1/12/2015Steven MizellVPSell20,500$118.72$2,433,760.00View SEC Filing  
11/17/2014Nicole M RingenbergVPSell12,780$118.83$1,518,647.40View SEC Filing  
10/15/2014Robert T FraleyEVPSell10,679$107.93$1,152,584.47View SEC Filing  
10/14/2014Nicole M RingenbergVPSell2,500$108.01$270,025.00View SEC Filing  
10/13/2014Steven MizellVPSell3,480$106.08$369,158.40View SEC Filing  
9/3/2014Kerry J PreeteEVPSell3,827$115.50$442,018.50View SEC Filing  
7/8/2014Michael J FrankVPSell7,500$124.53$933,975.00View SEC Filing  
7/7/2014Robert T FraleyEVPSell54,740$125.32$6,860,016.80View SEC Filing  
7/3/2014David F SnivelyEVPSell35,220$126.25$4,446,525.00View SEC Filing  
7/3/2014William U ParfetDirectorSell23,800$126.52$3,011,176.00View SEC Filing  
5/23/2014Janet M HollowaySVPSell21,280$120.00$2,553,600.00View SEC Filing  
5/7/2014Kerry PreeteEVPSell49,850$115.00$5,732,750.00View SEC Filing  
4/15/2014Hugh GrantCEOSell95,000$110.33$10,481,350.00View SEC Filing  
4/15/2014Tom HartleyVPSell7,900$110.51$873,029.00View SEC Filing  
1/17/2014Hugh GrantCEOSell44,179$112.69$4,978,531.51View SEC Filing  
1/16/2014Robert FraleyEVPSell64,850$112.57$7,300,164.50View SEC Filing  
1/14/2014Steven MizellVPSell24,000$112.05$2,689,200.00View SEC Filing  
11/11/2013Nicole RingenbergVPSell13,560$107.04$1,451,462.40View SEC Filing  
10/15/2013Tom HartleyVPSell5,860$105.70$619,402.00View SEC Filing  
10/8/2013Steven MizellVPSell11,370$104.50$1,188,165.00View SEC Filing  
10/7/2013Nicole RingenbergVPSell3,500$105.02$367,570.00View SEC Filing  
9/4/2013Kerry PreeteEVPSell5,276$99.00$522,324.00View SEC Filing  
7/19/2013Gerald A SteinerEVPSell12,293$104.00$1,278,472.00View SEC Filing  
7/9/2013Tom D HartleyVPSell6,000$100.15$600,900.00View SEC Filing  
7/8/2013Janet M HollowaySVPSell10,700$98.80$1,057,160.00View SEC Filing  
7/3/2013Hugh GrantCEOSell40,000$97.74$3,909,600.00View SEC Filing  
7/2/2013Steven MizellVPSell37,000$97.71$3,615,270.00View SEC Filing  
5/13/2013David F SnivelyEVPSell106,366$107.24$11,406,689.84View SEC Filing  
5/1/2013Pierre CourdurouxCFOSell5,720$105.47$603,288.40View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Monsanto (NYSE:MON)
News IconMonsanto Outsmarts the GMO Resistance (NYSE:MON) - September 24 at 5:42 PM
News IconMonsanto Agrees to Use Gene-Editing Tool CRISPR Responsibly (NYSE:MON) - September 24 at 5:42 PM
News IconOpposed to GMOs? What about Monsanto’s new CRISPR crops? (NYSE:MON) - September 24 at 5:42 PM
News IconMonsanto Strikes DNA-Editing Deal With Broad Institute, Harvard (NYSE:MON) - September 24 at 10:39 AM
News IconMonsanto cuts deal to use CRISPR to engineer food (NYSE:MON) - September 24 at 10:39 AM
News IconFood Blackmail: The Potential Danger of Bayer’s Purchase of Monsanto (NYSE:MON) - September 24 at 10:39 AM logoMonsanto : Secures Tech License from Broad Institute (NYSE:MON) - September 24 at 10:39 AM logoMonsanto signs license deal for gene-editing technology (NYSE:MON) - September 24 at 10:39 AM
News IconMonsanto Just Got Access to the World’s Most Powerful Gene-Editing Tool (NYSE:MON) - September 24 at 10:38 AM
News IconMonsanto Strikes DNA-Editing Deal With Broad Institute, Harvard - AgWeb (NYSE:MON) - September 23 at 5:49 PM logoMonsanto-Bayer Merger: Here's Why Investors Are Skeptical (NYSE:MON) - September 23 at 1:27 PM
News IconWhy is the U.S. government so keen to protect Monsanto? (NYSE:MON) - September 23 at 10:52 AM
News IconMonsanto Licenses Broad Institute CRISPR/Cas9 Technology (NYSE:MON) - September 23 at 10:52 AM
News IconCombined company will honor Monsanto's local commitments (NYSE:MON) - September 23 at 10:52 AM
News IconBig Pharma – Big Agra Mergers: Furthering the Synthetic Agenda (NYSE:MON) - September 23 at 10:52 AM
News IconMonsanto Has No Power Here: EU's Food Safety Commissioner (NYSE:MON) - September 23 at 10:52 AM
News Icon'A Five-Alarm Threat to Our Food Supply': Experts Describe Bayer-Monsanto Merger (NYSE:MON) - September 23 at 10:52 AM
News IconMonsanto To Use CRISPR Gene Editing Tech To Create New Seeds (NYSE:MON) - September 23 at 10:52 AM
News IconBayer-Monsanto deal pilloried by skeptical German lawmakers (NYSE:MON) - September 23 at 10:52 AM logoSold-out Farm Tank Summit raises frank discussion about agriculture, technology (NYSE:MON) - September 23 at 10:52 AM
News IconMonsanto Co. (NYSE: MON) Upgraded at JPMorgan Chase & Co. - The Ledger Gazette (NYSE:MON) - September 22 at 5:54 PM logo12:01 pm Monsanto reaches a global licensing agreement for the use of the CRISPR-Cas genome-editing technology in agriculture with the Broad Institute of MIT and Harvard (NYSE:MON) - September 22 at 5:54 PM logoMonsanto Announces Global Licensing Agreement with Broad Institute on Key Genome-Editing Application (NYSE:MON) - September 22 at 5:54 PM logoMonsanto may have just ended the war on GMOs (NYSE:MON) - September 22 at 5:54 PM logo[$$] Li Ka-shing means more ka-ching for Grid (NYSE:MON) - September 22 at 5:54 PM logoAltria Announces Consummation of Cash Tender Offer and Final Results (NYSE:MON) - September 22 at 5:54 PM
News IconBayer-Monsanto Merger Plan Draws US Senate Scrutiny - Voice of America (NYSE:MON) - September 22 at 10:59 AM logoBayer's Diligence Failure In Merck Deal Haunts Its Monsanto Purchase - Wall Street Journal (blog) (NYSE:MON) - September 21 at 5:52 PM logoBayer-Monsanto Mega Deal Pilloried by Skeptical German Lawmakers - Bloomberg (NYSE:MON) - September 21 at 5:52 PM logoBRIEF-Monsanto Co - Bayer not required to take any material adverse divest... - Reuters (NYSE:MON) - September 21 at 5:52 PM logoBRIEF-Monsanto Co - Bayer is committed to make divestitures to obtain anti... - Reuters (NYSE:MON) - September 21 at 5:52 PM logoBayer Might Drop Monsanto's Toxic Name (NYSE:MON) - September 21 at 5:52 PM logoBayer-Monsanto tie-up pilloried in Germany, U.S. (NYSE:MON) - September 21 at 3:53 PM logoMonsanto upgraded at J.P. Morgan (NYSE:MON) - September 21 at 3:53 PM logoMonsanto Upgraded Ahead of Buyout: 3 Things You Need to Know (NYSE:MON) - September 21 at 1:30 PM logoMonsanto, Bayer officials defend proposed $66 billion merger (NYSE:MON) - September 21 at 10:20 AM
News IconWill Monsanto Now Try To Hide? (NYSE:MON) - September 21 at 10:20 AM logoBayer Considers Letting Go of the Monsanto Name (NYSE:MON) - September 21 at 10:20 AM
News IconBayer outlines €10B new-drug sales target to allay post-Monsanto worries (NYSE:MON) - September 21 at 10:20 AM
News IconMonsanto, Bayer execs insist merger a benefit (NYSE:MON) - September 21 at 10:20 AM logoBayer Boss, Bullish on Growth, Defends Monsanto Deal (NYSE:MON) - September 21 at 10:20 AM logoMonsanto, Bayer Officials Defend Proposed Merger (NYSE:MON) - September 21 at 10:20 AM logoMonsanto (MON) Stock Higher, Upgraded at JPMorgan (NYSE:MON) - September 21 at 10:19 AM logoAnalysts' Actions -- Clovis, Altria, Sketchers, Wells Fargo and More (NYSE:MON) - September 21 at 10:19 AM logoNeo Technology and Monsanto to Co-Present at Strata + Hadoop World 2016 in New York (NYSE:MON) - September 21 at 10:19 AM logoBRIEF-Monsanto Co - Bayer is committed to make divestitures to obtain antitrust approvals (NYSE:MON) - September 21 at 8:45 AM logoBRIEF-Monsanto Co - Bayer not required to take any material adverse divestiture action (NYSE:MON) - September 20 at 6:40 PM logoBRIEF-Monsanto says bayer not required to take any divestiture action (NYSE:MON) - September 20 at 6:40 PM
News IconBayer, Monsanto to Create a Global Leader in Agriculture (NYSE:MON) - September 20 at 11:24 AM
News IconBayer-Monsanto deal making farmers uneasy (NYSE:MON) - September 20 at 11:24 AM


Monsanto (NYSE:MON) Chart for Sunday, September, 25, 2016

Last Updated on 9/25/2016 by Staff